Connect with us
Stanbic IBTC
Polaris bank
Fidelity ads

Business News

Japan’s Ohara Pharmaceutical takes over 20% stake in Fidson Healthcare

@FidsonHealthPLC has entered into a strategic partnership with Japan’s Ohara Pharmaceutical that will see the latter’s stake in the Nigerian company increase.



Ohara Pharmaceutical increases stake in Fidson, Fidson and Ohara signs partnership, Nairametrics news, Naija News, Fidson list additional shares Fidson and GSK business partnership

Pharmaceutical firm, Fidson Healthcare Plc, has entered into a strategic partnership with Japan’s Ohara Pharmaceutical that will see the latter’s stake in the Nigerian company increase.

The deal involves a right issue which grew Ohara’s shares in Fidson Healthcare to 21.75%. This is a strategic capital and business alliance between both companies that will provide both the Nigerian and Japanese markets the latest products and services in healthcare.

Fidson had listed 586,360,250 ordinary shares by way of Rights Issue on Monday, July 1, 2019. These additional shares listed, according to a statement sent to the Nigerian Exchange Commission (NSE), arose from Fidson Healthcare’s Rights Issue of 750,000,000 ordinary shares of 50 kobo each at N4.00 per share on the basis of 1 new ordinary share for every 2 ordinary shares held as at December 28 2018.

[READ ALSO: 46-years after, Mr. Bigg’s is not so big anymore]

Fidson was only able to raise 78.18% of what it’s expected to raise. This makes the total issued and fully paid up shares of Fidson Healthcare to increase to 2,086,360,250 ordinary shares from 1,500,000,000 after the additional 586,360,250 ordinary shares. Nairametrics learnt the company raised N2.3 billion falling short of its N3 billion target.

Rights issue, which is also known as rights offer, gives existing shareholders of a company an opportunity or right to increase their shares by purchasing new shares. This enables existing shareholders to buy shares at a discount to the market price.

Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership

Fidson Healthcare Plc

Part of the agreement will see Ohara enhance Fidson’s services and products by making pharmaceuticals and medical devices available to the company. These innovations and technology is expected to help Fidson compete better in the local healthcare.

Deal book 300 x 250

According to the statement on NSE’s website, Fidson said, “The alliance holds promise as a significant growth driver for both companies, particularly as a major factor for the development of local pharmaceutical manufacturing in Nigeria.

“Given this growing population, there is no doubt that Nigeria is in urgent need of a rapid improvement in the standard of healthcare delivery. This can only be accelerated through modernisation and technological intervention which the alliance with Ohara aims to deliver.”

[READ MORE: ENI’s MD is furious after being linked to Nigerian fraud case]

Fidson is prepared choice for GSK: Nairametrics had reported that GlaxoSmithKline Consumer Nigeria Plc had chosen Fidson as its preferred local contract manufacturing partner. GSK will thus transition the manufacturing of its respiratory and wellness products to Fidson from the third quarter of 2021. The firm, however, maintained that activities would continue at its Agbara plant till then.

About Ohara Pharmaceutical: Ohara is a pharmaceutical company focusing on the businesses of orphan drugs and generic drugs. The company focuses on the development and marketing of orphan drugs, mainly in the field of pediatric oncology and on the development, manufacturing and marketing of generic drugs that give extra consideration to the prevention of medical accidents. Ohara plans to further expand these businesses into emerging countries, primarily in the Asian and African regions.

bitcoin train


Olalekan is a certified media practitioner from the Nigerian Institute of Journalism (NIJ). In the era of media convergence, Olalekan is a valuable asset, with ability to curate and broadcast news. His zeal to write was developed out of passion to shape people’s thought and opinion; serving as a guideline for their daily lives. Contact for tips: [email protected]

Click to comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.



Nairametrics | Company Earnings